Bert H. O’Neil
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies 91
- Pancreatic and Hepatic Oncology Research 39
- Cancer Treatment and Pharmacology 35
- Cancer Immunotherapy and Biomarkers 26
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 40
- Cancer Research top 1%
- Pathology and Forensic Medicine top 0.5%
-
- Gastric Cancer Management and Outcomes 24
- Lung Cancer Treatments and Mutations 24
-
- Colorectal and Anal Carcinomas 24
- Co-authors
- Richard M. GoldbergElizabeth Claire DeesSarina A. Piha‐PaulSafi ShahdaAlan P. VenookRobert Z. OrlowskiPeter M. VoorheesHeinz‐Josef Lenz
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (99 papers)Annals of Oncology (20 papers)The Oncologist (9 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Bert H. O’Neil
243 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 5.7k
- Hepatology 1.1k
- Cancer Research 1.3k
- Pathology and Forensic Medicine 1.3k
- Pulmonary and Respiratory Medicine 2.0k
Countries citing papers authored by Bert H. O’Neil
This map shows the geographic impact of Bert H. O’Neil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert H. O’Neil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert H. O’Neil more than expected).
Fields of papers citing papers by Bert H. O’Neil
This network shows the impact of papers produced by Bert H. O’Neil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert H. O’Neil. The network helps show where Bert H. O’Neil may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bert H. O’Neil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 20 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 9 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 146 | |
| 10 | 2019 | 44 | |
| 11 | 2019 | 116 | |
| 12 | 2018 | 27 | |
| 13 | T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028breakdown → | 2018 | 656 |
| 14 | 2017 | 1 | |
| 15 | 2017 | 27 | |
| 16 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trialbreakdown → | 2017 | 386 |
| 17 | Mental Health Outcomes during Colorectal Cancer Survivorship: A Review of the Literature | 2016 | 2 |
| 18 | The Role of HIPEC in Gastrointestinal Malignancies: Controversies and Conclusions. | 2015 | 1 |
| 19 | Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomasbreakdown → | 2005 | 503 |
| 20 | 2005 | 290 |
About Bert H. O’Neil
Bert H. O’Neil is a scholar working on Oncology, Hepatology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 255 papers that have together received 9.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (91 papers), Hepatocellular Carcinoma Treatment and Prognosis (40 papers), Pancreatic and Hepatic Oncology Research (39 papers), Cancer Treatment and Pharmacology (35 papers), Cancer Immunotherapy and Biomarkers (26 papers), Colorectal and Anal Carcinomas (24 papers), Gastric Cancer Management and Outcomes (24 papers) and Lung Cancer Treatments and Mutations (24 papers). The work is most often cited by research in Oncology (5.7k citations), Hepatology (1.1k citations), Cancer Research (1.3k citations), Pathology and Forensic Medicine (1.3k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Bert H. O’Neil has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Richard M. Goldberg, Elizabeth Claire Dees, Sarina A. Piha‐Paul, Safi Shahda, Alan P. Venook, Robert Z. Orlowski, Peter M. Voorhees, Heinz‐Josef Lenz, Patrick A. Ott and Hope S. Rugo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Clinical Cancer Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.